Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open-Label, Randomized Study: Results From a Phase IIIb/IV Open-Label, Randomized Study

Research output: Contribution to journal › Article › Academic › peer-review

4 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open-Label, Randomized Study: Results From a Phase IIIb/IV Open-Label, Randomized Study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science